103-32-2c1ccc(CNc2ccccc2)cc1GTWJETSWSUWSEJ-UHFFFAOYSA-Nmajor metabolite of antazoline; RN given refers to parent cpd
103-32-2DTXSID7059272CHEMBL237223Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Benzenemethanamine, N-phenyl-
Benzenemethanamine, N-phenyl-: Does not have an individual approval but may be used under an appropriate group standard
UsesN-Benzylaniline is a major metabolite of the antihistaminic Antazoline and other N-substituted benzylanilines.
UsesN-Benzylaniline was used in the separation of tervalent gallium, indium and thallium by solvent extraction method.
General DescriptionThe electropolymerisation of N-benzylaniline at transparent Indium Tin Oxide glass electrodes has been investigated by UV-visible spectroelectrochemistry. N-Benzylaniline on electrochemical oxidation in aqueous sulfuric acid solution produces an adherent conducting polymer film at the platinum electrode.